» Articles » PMID: 32345225

Higher Fatty Liver Index is Associated with Increased Risk of New Onset Heart Failure in Healthy Adults: a Nationwide Population-based Study in Korea

Overview
Publisher Biomed Central
Date 2020 Apr 30
PMID 32345225
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Heart failure (HF) is relatively common cardiovascular disease with high mortality and morbidity. Although it is associated with many cardiovascular risk factors, the association between nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease, and HF has not been evaluated in a large-scale cohort study. Thus, we evaluated the ability of the fatty liver Index (FLI), a surrogate marker of NAFLD, to predict the development of HF in healthy individuals.

Methods: We analyzed the association between the FLI and new-onset HF with multivariate Cox proportional-hazards models in 308,578 healthy persons without comorbidities who underwent the National Health check-ups in the republic of Korea from 2009 to 2014.

Results: A total of 2532 subjects (0.8%) were newly diagnosed with HF during the study period (a median of 5.4 years). We categorized our subjects into quartile groups according to FLI (Q1, 0-4.9; Q2, 5.0-12.5; Q3, 12.6-31.0; and Q4, > 31.0). The cumulative incidence of HF was significantly higher in the highest FLI group than in the lowest FLI group (Q1, 307 [0.4%] and Q4, 890 [1.2%]; P < 0.001). Adjusted hazard ratio (HRs) indicated that the highest FLI group was independently associated with an increased risk for HF (HR between Q4 and Q1, 2.709; 95% confidence interval = 2.380-3.085; P < 0.001). FLI was significantly associated with an increased risk of new-onset HF regardless of their baseline characteristics.

Conclusions: Higher FLI was independently associated with increased risk of HF in a healthy Korean population.

Citing Articles

Non-Invasive Serum Markers of Non-Alcoholic Fatty Liver Disease Fibrosis: Potential Tools for Detecting Patients with Cardiovascular Disease.

Chen L, Jing X, Chen X, Xie Y, Chen Y, Cai X Rev Cardiovasc Med. 2024; 25(9):344.

PMID: 39355605 PMC: 11440407. DOI: 10.31083/j.rcm2509344.


Concentric remodeling and the metabolic-associated steatotic liver disease in patients with type 1 diabetes: an exploratory study.

Czarnik K, Sablik Z, Borkowska A, Drozdz J, Cypryk K Acta Diabetol. 2024; 62(3):385-395.

PMID: 39287794 PMC: 11872745. DOI: 10.1007/s00592-024-02365-3.


The association of fatty liver index and metabolic syndrome with cardiovascular outcomes, liver-related mortality, and all-cause mortality: a nationwide cohort study.

Park S, Park J, Kim H, Lee J, Kwon S, Lee Y Intern Emerg Med. 2024; 20(1):105-117.

PMID: 39235708 DOI: 10.1007/s11739-024-03758-6.


Survival benefit of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a nationwide cohort study.

Shin J, Park S, Lee J, Lee J Sci Rep. 2024; 14(1):14703.

PMID: 38926519 PMC: 11208440. DOI: 10.1038/s41598-024-65763-1.


Association between non-alcoholic fatty liver disease and subclinical left ventricular dysfunction in the general population.

Hirose K, Nakanishi K, Di Tullio M, Homma S, Sawada N, Yoshida Y Eur Heart J Open. 2023; 3(6):oead108.

PMID: 37941727 PMC: 10630098. DOI: 10.1093/ehjopen/oead108.


References
1.
Reaven G, Hoffman B . A role for insulin in the aetiology and course of hypertension?. Lancet. 1987; 2(8556):435-7. DOI: 10.1016/s0140-6736(87)90968-8. View

2.
Warner F, Lubel J, McCaughan G, Angus P . Liver fibrosis: a balance of ACEs?. Clin Sci (Lond). 2007; 113(3):109-18. DOI: 10.1042/CS20070026. View

3.
Angulo P, Kleiner D, Dam-Larsen S, Adams L, Bjornsson E, Charatcharoenwitthaya P . Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015; 149(2):389-97.e10. PMC: 4516664. DOI: 10.1053/j.gastro.2015.04.043. View

4.
Jung J, Park S, Ryoo J, Oh C, Kang J, Lee J . Effect of non-alcoholic fatty liver disease on left ventricular diastolic function and geometry in the Korean general population. Hepatol Res. 2016; 47(6):522-532. DOI: 10.1111/hepr.12770. View

5.
Lee J, Lim N, Cho M, Park H . Epidemiology of Heart Failure in Korea: Present and Future. Korean Circ J. 2016; 46(5):658-664. PMC: 5054178. DOI: 10.4070/kcj.2016.46.5.658. View